A patient with medullary thyroid carcinoma and right ventricular cardiac metastasis treated by 90Y-Dotatoc

Hellenic Journal of Nuclear Medicine

Volumn 12, Issue 2, 2009, Pages

  Bertagna, Francesco ^a,e   Giubbini, Raffaele ^a   Savelli, Giordano ^a   Pizzocaro, Claudio ^a   Rodella, Carlo ^b   Biasiotto, Giorgio ^c   Lucchini, Silvia ^a   Maroldi, Roberto ^b   Rosenbaum, Joshua ^d   Alavi, Abass ^d  

^a University and Public Clinic   (Italy)

^b Public Hospital   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Civic Hospital of Brescia   (Italy)

Author keywords

111In octreotide; 18F fDG; Cardiac metastasis; Medullary thyroid carcinoma; PET CT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITONIN; CALCIUM ANTAGONIST; DOTATOC YTTRIUM 90; FLUORODEOXYGLUCOSE F 18; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CERVICAL SPINE RADIOGRAPHY; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ECHOCARDIOGRAPHY; HEART METASTASIS; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE DYSPLASIA; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS VERTEBROPLASTY; PHASE 2 CLINICAL TRIAL; THORAX RADIOGRAPHY; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

AGED; CARCINOMA, MEDULLARY; HEART NEOPLASMS; HEART VENTRICLES; HUMANS; MALE; OCTREOTIDE; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 69249182672     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. 111In-Octreotide scan. Hell J Nucl Med 2005; 8: 43-47. (Pubitemid 40723741)
2. 111In-pentetreotide in patients with advanced neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2004; 31: 1386-1392. (Pubitemid 39361934)
3. 111In-DTPA- octreotide. Eur J Nucl Med 2001; 28: 1743-1750. (Pubitemid 33141237)
4. Cremonesi M, Ferrari M, Bodei L et al. Systemic and locoregional dosimetry in receptor radionuclide treatment with peptides. Q J Nucl Med Mol Imaging 2006; 50: 288-295. (Pubitemid 46157610)
5. 90Y-conjugates: risks and safety. Eur J Nucl Med Mol Imaging 2006; 33: 1321-1327. (Pubitemid 44630788)
6. 90Y-DOTATOC therapies in patients with neuroendocrine tumors. Cancer Biother Radiopharm 2007; 22: 130-135. (Pubitemid 46697375)
7. 90Y-DOTATOC. Eur J Nucl Med 1999; 26: 877-886. (Pubitemid 29397000)
8. Cremonesi M, Ferrari M, Bodei L et al. Dosimetry in peptide radionuclide receptor treatment: a review. J Nucl Med 2006; 47: 1467-1475. (Pubitemid 47544933)
9. Siegel JA, Thomas SR, Stubbs JB et al. MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 1999; 40: 37S-61S.
10. Stabin GM, Sparks RB, Crowe E. OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear Medicine. J Nucl Med 2005; 46: 1023-1027. (Pubitemid 43733519)
11. Sgouros G. Dosimetry of internal emitters. J Nucl Med 2005; 46: Suppl 1: 18-27.
12. Brans B, Bodei L, Giammarile F et al. Clinical radionuclide treatment dosimetry: the quest forthe "Holy Gray". Eur J Nucl Med Mol Imaging 2007; 34: 772-786.
13. 90Y-DOTA,Tyr3) octreotide accurate enough to predict thresholds for individual patients? Cancer Biother Radiopharm 2003; 18: 619-625.
14. 90Y-DOTATOC treatment. Eur J Nucl Med Mol Imaging 2006; 33: 460-466.
15. 90Y-DOTATOC treatment. Eur J Nucl Med Mol Imaging 2006; 33: 1115-1122. (Pubitemid 44484467)
16. 68Ga-DOTATOC: Biodistribution and dosimetry in patients affected by neuroendocrine tumors. Eur J Nucl Med Mol imaging 2008; 35: 72-79. (Pubitemid 350234154)
17. Antunes P, Ginj M, Zhang H et al. Are radiogallium-labelled DOTA-conjugated somatostatina analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging 2007; 34: 982-993.
18. 18F-fluorodeoxyglucose and Positron Emission Tomography: Review and 1999 EORTC Recommendations. Europ J Cancer 1999; 35: 1773-1782.
19. Hoff AO, Hoff PM. Medullary Thyroid carcinoma. Hematol Oncol Clin North Am 2007; 2: 475-488.
20. Moley JF, Fialkowski EA. Evidence-based approach to the management of sporadic MTC. World J Surg 2007; 31: 946-956.
21. Pandya UH, Pellikka PA, Enriquez-Sarano M et al. Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients. JACC 2002; 40: 1328-1332.
22. th edn vol.2 McGraw-Hill, New York, NY, 1994; 2011-2019.
23. Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. J Clin Pathol 2007; 60: 27-34.
24. Goddard MJ, Atkinson C. Cardiac metastasis from a bronchial carcinoid: report of a case presenting with diffuse thickening of the left ventricular wall. J Clin Pathol 2004; 57: 778-779. (Pubitemid 38901500)
25. Tesolin M, Lapierre C, Oligny L et al. Cardiac metastases from melanoma. Radiographics 2005; 25: 249-253.
26. Ozyuncu N, Sahin M, Altin T et al. Cardiac metastasis of malignant melanoma: a rare cause of complete atrioventricular block. Europace 2006; 8: 545-548. (Pubitemid 43985495)
27. Poh KK, Avelar E, Hua L, King ME. Cardiac metastases from malignant melanoma. Clin Cardiol 2007; 30: 359-360.
28. Marti G, Galve E, Huguet J, Soler J. Cardiac metastases of malignant melanoma mimicking sick sinus syndrome. Rev Esp Cardiol 2004; 57: 589-591. (Pubitemid 38997119)
29. Basarici I, Demir I, Yilmaz H, Altekin RE. Obstructive metastatic malignant melanoma of the heart: imminent pulmonary arterial occlusion caused by right ventricular metastasis with unknown origin of the primary tumor. Heart Lung 2006; 35: 351-354. (Pubitemid 44331950)
30. Shimura M, Fujita Y, Hiramatsu M et al. Primary lung cancer with myocardial metastasis mimicking acute myocardial infarction. Nihon Kokyuki Gakkai Zasshi 2007; 45: 704-708.
31. Zattera GF, Alloni A, D'Armini AM et al. Solitary cardiac metastases from a clear cell carcinoma of the kidney. A case report and a review of the literature. J Cardiovasc Surg 2004; 45: 573-576. (Pubitemid 41490615)
32. Suda T, Ishii A, Hukuda K et al. Cardiac metastasis by hypopharyngeal carcinoma. Case report. Nippon Jibiinkoka Gakkai Kaiho 2007; 110: 466-469.
33. Yap CH, Hair C, Foy S et al. Resection of right atrial metastatic large-cell neuroendocrine carcinoma. Asian Cardiovasc Thorac Ann 2007; 15: 20-22.
34. Page E, Fric D, Barjhoux JL et al. Cardiac metastasis from a Merkel cell skin carcinoma. A case report. Arch Mal Coeur Vaiss 2001; 94: 1423-1426.
35. Bernheim AM, Connolly HM, Hobday TJ et al. Carcinoid heart disease. Prog Cardiovasc Dis 2007; 49: 439-451.
36. Drake WM, Jenkins PJ, Phillips RR et al. Intracardiac metastases from neuroendocrine tumors. Clin Endocrinol (Oxf) 1997; 46: 517-522.
37. Conley M, Hawkins K, Ririe D. Complete heart block and cardiac tamponade secondary to Merkel Cell Carcinoma cardiac metastases. South Med J 2006; 99: 74-78.
38. Collins N, Bellamy G, Hayes P. Intrapericardial carcinoid metastasis. J Am Soc Echocardiol 2004; 17: 675-676.
39. Moller JE, Pellikka PA, Bernheim AM et al. Prognosis of carcinoid heart disease. Analysis of 200 cases over two decades. Circulation 2005; 112: 3320-3327.
40. Wee J, Sepic JD, Mihaljevic T, Cohn LH. Metastatic carcinoid tumor of the heart. Ann Thorac Surg 2003; 76: 1721-1722.
41. McCormick D. Carcinoid tumors and syndrome. Gastroenterol Nurs 2002; 25: 105-111.
42. Bernheim AM, Connolly HM, Pellikka PA. Carcinoid heart disease in patients without hepatic metastases. Am J Cardiol 2007; 99: 292-294. (Pubitemid 46072772)
43. Gonzalez Cao M, Bastarrika G, Garcia-foncillas J et al. Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacement. Clin Transl Oncol 2006; 8: 369-371